enow.com Web Search

  1. Ads

    related to: medication for ulcerative colitis

Search results

  1. Results from the WOW.Com Content Network
  2. Ulcerative colitis - Wikipedia

    en.wikipedia.org/wiki/Ulcerative_colitis

    The first-line maintenance medication for ulcerative colitis in remission is mesalazine (also known as mesalamine or 5-ASA). [95] [96] For patients with active disease limited to the left colon (descending colon) or proctitis, mesalazine is also the first-line agent, and a combination of suppositories and oral mesalazine may be tried.

  3. FDA-approved drug for ulcerative colitis also effective for ...

    www.aol.com/fda-approved-drug-ulcerative-colitis...

    Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, also sends Crohn's disease into clinical remission, new findings suggest.

  4. Management of ulcerative colitis - Wikipedia

    en.wikipedia.org/wiki/Management_of_ulcerative...

    Immunosuppressive drugs used with ulcerative colitis include: Mercaptopurine, also known as 6-Mercaptopurine, 6-MP and Purinethiol. Azathioprine, also known as Imuran (US) or Azasan, which metabolises to 6-MP. Methotrexate, which inhibits folic acid. Mercaptopurine is a cytostatic drug that is an antimetabolite.

  5. Mesalazine - Wikipedia

    en.wikipedia.org/wiki/Mesalazine

    Mesalazine, also known as mesalamine or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. [1] It is generally used for mildly to moderately severe disease. [1] It is taken by mouth or rectally. [1]

  6. Targeted therapy may help treat moderate to severe ulcerative ...

    www.aol.com/targeted-therapy-may-help-treat...

    One study found that the medication tulisokibart may help people with moderate to severe ulcerative colitis achieve clinical remission. Ulcerative colitis is a chronic condition characterized by ...

  7. Vedolizumab - Wikipedia

    en.wikipedia.org/wiki/Vedolizumab

    Vedolizumab, sold under the brand name Entyvio, is a monoclonal antibody medication developed by Takeda Oncology for the treatment of ulcerative colitis and Crohn's disease. [5] It binds to integrin α 4 β 7 ( LPAM-1 , lymphocyte Peyer's patch adhesion molecule 1, a dimer of Integrin alpha-4 and Integrin beta-7 ), [ 5 ] [ 6 ] blocking the α 4 ...

  1. Ads

    related to: medication for ulcerative colitis